OCULAR THERAPEUTIX, INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ocular Therapeutix, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Ocular Therapeutix, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $184M, a 11.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $184M +$19.2M +11.7% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $165M +$21.9M +15.4% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $143M +$19.6M +15.9% Dec 31, 2021 10-K 2024-03-11
Q4 2020 $123M +$18M +17.1% Dec 31, 2020 10-K 2024-03-11
Q4 2019 $105M +$20.7M +24.6% Dec 31, 2019 10-K 2023-03-06
Q4 2018 $84.3M +$16.6M +24.5% Dec 31, 2018 10-K 2022-02-28
Q4 2017 $67.7M -$2.51M -3.57% Dec 31, 2017 10-K 2020-03-12
Q4 2016 $70.2M +$18.3M +35.2% Dec 31, 2016 10-K 2020-03-12
Q4 2015 $52M +$15.1M +41.1% Dec 31, 2015 10-K 2019-03-07
Q4 2014 $36.8M +$11M +42.9% Dec 31, 2014 10-K 2018-03-08
Q4 2013 $25.8M +$5.96M +30.1% Dec 31, 2013 10-K 2017-03-10
Q4 2012 $19.8M +$5.64M +39.8% Dec 31, 2012 10-K 2016-03-10
Q4 2011 $14.2M Dec 31, 2011 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.